Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146 | 736 | 395 | 304 | 737 |
| Marketable Securities | N/A | N/A | 33 | 569 | 1,053 |
| Receivables | 3 | 5 | 16 | 24 | 15 |
| Other current assets | 0 | 0 | 0 | 0 | 116 |
| TOTAL | $156 | $855 | $561 | $1,011 | $1,921 |
| Non-Current Assets | |||||
| Intangibles | 256 | 270 | 276 | 271 | 0 |
| Other Non-Current Assets | 0 | 140 | 138 | 134 | 417 |
| TOTAL | $256 | $409 | $414 | $405 | $417 |
| Total Assets | $413 | $1,265 | $975 | $1,416 | $2,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 299 | 329 | 511 | 831 | 1,147 |
| Accounts payable and accrued liabilities | 753 | 257 | 1,093 | 221 | 224 |
| TOTAL | $1,052 | $586 | $1,604 | $1,052 | $1,371 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,052 | $586 | $1,604 | $1,052 | $1,371 |
| Shareholders' Equity | |||||
| Common Shares | 10,312 | 10,871 | 8,390 | 8,045 | 8,021 |
| Retained earnings | -13,688 | -13,087 | -12,046 | -10,531 | -9,966 |
| Other shareholders' equity | 2,737 | 2,896 | 3,027 | 2,851 | 2,912 |
| TOTAL | $-639 | $679 | $-629 | $364 | $967 |
| Total Liabilities And Equity | $413 | $1,265 | $975 | $1,416 | $2,338 |